/
•
•
Detailed stories on technology startups, business and economic current affairs.
The quiet, conservative Ahmedabad-based drug maker is ready to pledge family silver to acquire a rival many times its size. The question is whether it can survive its ambition.

The quiet, conservative Ahmedabad-based drug maker is ready to pledge family silver to acquire a rival many times its size. The question is whether it can survive its ambition.

The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
With a promoter who is unafraid to make bold bets and pivot to businesses holding more promise, investors can only look forward to better times.
The Hyderabad-based generics maker has seen its stock scale all-time highs and lows in quick succession. With big plans in place and regulatory heat easing, its roller-coaster days may be over.
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
With a promoter who is unafraid to make bold bets and pivot to businesses holding more promise, investors can only look forward to better times.
The Hyderabad-based generics maker has seen its stock scale all-time highs and lows in quick succession. With big plans in place and regulatory heat easing, its roller-coaster days may be over.